During NAFLD progression, inflammation of visceral adipose tissue may trigger the activation of proinflammatory pathways (JNK and NF-κB) and downstream synthesis of procoagulant factors, collectively causing increased CVD risk [43]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.